期刊文献+

卡前列腺素氨丁三醇治疗产后出血31例 被引量:7

Hemabate for Treating 31 Cases of Postpartum Hemorrhage
下载PDF
导出
摘要 目的探讨卡前列腺素氨丁三醇(欣母沛)治疗产后出血的临床疗效及安全性。方法选择医院2011年12月至2012年10月收治产后出血的产妇62例,随机分成两组,各31例,对照组给予缩宫素20 U注射和口服米索前列醇400μg;治疗组在对照组基础上给予卡前列腺素氨丁三醇250μg肌肉注射,效果不佳者可再次注射。比较两组患者的临床疗效、治疗后各时段出血量及不良反应发生情况。结果治疗组总有效率为96.77%,明显高于对照组的83.87%(P<0.05),各时段出血量均显著少于对照组(P<0.05);治疗组在治疗过程中出现恶心呕吐3例,发热1例,面色潮红5例,胸闷1例,血压一过性升高2例,均未经处理可自行缓解。结论卡前列腺素氨丁三醇治疗产后出血疗效显著,不但起效迅速、使用方便、安全可靠,还可预防并发症的发生,值得临床推广。 Objective To investigate the clinical efficacy and safety of carboprost trometamol (hemabate) for treating postpartum hemor- rhage. Methods 62 cases of postpartum hemorrhage in our hospital from December 2011 to October 2012 were selected and randomly divided into two groups, 31 cases in each group. The control group was given oxytoein 20U by injection and oral misoprostol 400 txg; the treatment group was given hemabate 250 μg by intramuscular injection based on the basis of the control group, if the effect was not optimal, reinjection was conducted. The clinical efficacies, bleeding amounts at different time intervals after treatment and adverse re- actions were compared between the two groups. Results The total effective rate was 96.77% in the treatment group, which was signifi- cantly higher than 83.87% in the control group (P〈 0.05); the bleeding amounts of different time intervals in the treatment group were significantly less than those in the control group with statistical difference between the two groups (P 〈 0. 05); during the treat- ment process in the treatment group, 3 cases of nausea and vomiting, 1 case of fever, 5 cases of facial flushing, 1 case of chest pain and 2 cases of transiently increased blood pressure appeared, the symptoms all could be spontaneously alleviated without treatment. Conclusion Hemabate in the treatment of postpartum hemorrhage has significantly efficacy and rapid onset of action, is easy to use, safe and reliable, also can prevent the occurrence of complications, which deserves to be promoted and applied in clinic.
作者 沈春波
出处 《中国药业》 CAS 2013年第9期43-44,共2页 China Pharmaceuticals
关键词 卡前列腺素氨丁三醇 缩宫素 产后出血 carboprost trometamol oxytocin postpartum hemorrhage
  • 相关文献

参考文献8

二级参考文献43

  • 1许琴仙,郑培兰.欣母沛预防和减少剖宫产术后出血的疗效分析[J].现代中西医结合杂志,2007,16(23):3306-3307. 被引量:3
  • 2贾金平.46例产后失血性休克临床分析[J].中国妇幼保健,2006,21(6):748-749. 被引量:13
  • 3姚丽群.欣母沛预防及治疗剖宫产产后出血的临床观察[J].现代医学,2007,35(2):99-100. 被引量:12
  • 4孙忠实,史亦丽.国家新药新制剂总览[M]北京:化学工业出版社,2002:371.
  • 5乐杰.妇产科学[M].7版.北京:人民卫生出版社,2009:92-99.
  • 6Tuzovic L,Djelmis J ,Ilijic M.Obstetric risk factors associated with placenta previa development :case-control study[J].Croat Med J,2003, 44(6) :728.
  • 7Faiz AS,Ananth CV.Etiology and risk factors for placentaprevia:an overview and metanalysis of observational studied[J].J Matern FetalNeonatal Med, 2003,13 : 175.
  • 8Johnson L G, Mueller BA, Daling J R.The relationship of placenta previa and history of induced abortion[J].Int J Gynaecol Obstet, 2003,81 : 191.
  • 9Dashe JS, McIntire DD,Ramus RM,et al.Persistence of placenta previa according to gestational age at ultrasound detection[J].Obstet Gynecol, 2002,99 : 692.
  • 10Hendricks MS, Chow YH, Bhagavath B, et al.Previous cesarean section and abortion as risk factors for developing placenta previa[J].J Obstet Gynaecol Res, 1999,25 : 137.

共引文献91

同被引文献49

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部